SCHEMBL10923076

SCHEMBL10923076

COC(=O)Oc1c(C)nc(C)c(OC(=O)OCCO)c1-c1ccccc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.40
▸ HSD17B10 Q99714 6/20 0.40
▸ HPGD P15428 4/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ AHR P35869 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ VDR P11473 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ SHMT2 P34897 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10913977 0.93 KDM4E (0.42) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL10914725 0.91 CPB1 (0.36) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL10913659 0.84 LDHA (0.39) KDM4EHSD17B10SMN1; SMN2ALDH1A1CYP1A2
SCHEMBL10911579 0.83 ALDH1A1 (0.39) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL10915061 0.82 PTPN11 (0.41) CTSA
SCHEMBL10913013 0.77 SMN1; SMN2 (0.34) SMN1; SMN2MAPTTSHR
SCHEMBL10748805 0.77 CACNB4 (0.46) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL10926337 0.76 LDHA (0.40) KDM4EHSD17B10HPGDRAB9ASMN1; SMN2
SCHEMBL10910590 0.75 LDHA (0.38) HSD17B10SMN1; SMN2ALDH1A1CYP1A2TSHR
SCHEMBL10913839 0.75 HRH2 (0.40) KDM4EHPGDRAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0088938-B1 USE OF PYRIDINE COMPOUNDS FOR THE MANUFACTURE OF MEDICAMENTS WITH AN ANTIHYPOXEMIA AND ISCHEMIA-PROTECTIVE ACTIVITY BAYER AG (DE) 1986-04-30 — — EP disclosed
EP-0088940-A1 Pyridine-carboxylic-acid esters, process for their preparation and their use as pharmaceutical compositions BAYER AG (DE) 1983-09-21 — — EP disclosed
Send feedback